Least square mean calculation for the fully replicate design [General Sta­tis­tics]

posted by Jaimik Patel – India, 2019-10-31 11:19  – Posting: # 20737
Views: 561

Dear All,

One question for the least square mean calculation for the fully replicate design as per USFDA in SAS.

We performed the statistical analysis using the code provided in progesterone guideline and Least square mean values of AUCi parameter for the Test and Reference are 6.112006 and 6.111151 respectively.

Unfortunately, after statistical analysis, one error was identified by sponsor in bio-analysis of sample in test formulation. Only one value in particular time point of one period in one subject got changed. Hence, Statistical analysis performed again and it was observed that Least square mean values of AUCi for Test and Reference are 6.111382 and 6.110883. The change in the value of test product results in the change in LSM value in reference product!!

The question is, reference product data remain the same, there is not a single value change in reference data then why Least square mean value of reference product changed AUCi parameter. Why this is affecting the reference data? :confused:

I have also perform the same experiments in two way study design but in that if I am changing any reference data it is not impacting on least square test data.

Please share your thoughts … :-)

Thanks !!
Jaimik


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,987 posts in 4,229 threads, 1,374 registered users;
online 12 (1 registered, 11 guests [including 6 identified bots]).
Forum time (Europe/Vienna): 18:59 CET

To know the history of science is to recognize the mortality
of any claim to universal truth.    Evelyn Fox Keller

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5